相关实验视频
Updated: May 29, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.0K
发现氨酸结合醇作为潜在的抗糖尿病剂:合成,生物评估和分子对接研究
Betül Kaya1, Hakan Tahtacı2, Bilge Çiftçi3
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
Drug development research
|February 5, 2025
概括
新的提亚衍生物显示出对关键糖尿病酶的有前途的抑制活性,包括阿尔多减少酶和α-糖酶. 这些发现表明开发新型抗糖尿病化合物的潜力.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病是一种慢性代谢障碍,其特征是高血糖.
- 诸如阿尔多减少酶 (AR),α-糖化酶 (α-GLY) 和α-氨基酶 (α-AMY) 等酶是糖尿病管理的关键标.
- 开发这些酶的新型抑制剂对于有效治疗糖尿病至关重要.
研究的目的:
- 为了合成和表征新型的氨酸结合 thiazole 衍生物.
- 评估这些衍生物对AR,α-GLY和α-AMY的抑制潜力.
- 用分子对接研究来支持实验发现.
主要方法:
- 汉茨赫的提亚合成被用来获得提亚衍生物 (3a-3j).
- 用质谱 (MS),H NMR和C NMR进行了表征.
- 进行了酶抑制测定和分子对接模拟.
主要成果:
- 合成的衍生品 (3a-3j) 对向酶具有不同程度的抑制活性.
- 观察到强烈的抑制,AR的KI值从5.47 ± 0.53到23.89 ± 1.46nm不等,α-GLY从1.76 ± 0.01到24.81 ± 0.15μM不等.
- 对α-AMY的IC50值在4.94至28.17μM之间,与标准epalrestat和acarbose相比显示出显著的活性.
结论:
- 新型醇衍生物显示出作为糖尿病相关酶的抑制剂的显著潜力.
- 它们的选择性活动表明,开发新的糖尿病治疗药物具有前途.
- 对这些化合物的进一步研究可能会导致糖尿病的替代治疗方法.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
162
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
162
Antihypertensive Drugs: Thiazide-Class Diuretics
525
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
525
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Oral Hypoglycemic Agents: Sulfonylureas
184
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
184
Oral Hypoglycemic Agents: Glinides
133
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
133
Diazonium Group Substitution: –OH and –H
2.7K
Nitrous acid, a weak acid, is prepared in situ via the reaction of sodium nitrite with a strong acid under cold conditions. This nitrous acid prepared in situ reacts with primary arylamines to form arenediazonium salts. Such reactions are known as diazotization reactions. As shown in Figure 1, the formation of arenediazonium salts begins with the decomposition of nitrous acid in an acidic solution to give nitrosonium ions.
2.7K

